Which of the following is NOT a benefit of a Drug Utilization Review (DUR)?

The identification of over-the-counter (OTC) medications is not a primary benefit of a Drug Utilization Review (DUR). DUR is a formal review process that focuses on evaluating the appropriateness of medications prescribed to patients, as well as their safe and effective use. Its primary aims include enhancing patient safety by reducing medication errors, optimizing therapeutic outcomes, and ensuring adherence to clinical guidelines.

While identifying OTC medications can be part of a more extensive patient assessment, the core focus of DUR is more aligned with monitoring prescribed medications and managing drug interactions, side effects, and adherence to therapy. The other options highlight crucial outcomes of DUR, such as improving patient safety, ensuring cost control for patients and providers, and minimizing medication errors—all central to enhancing patient care and medication management.